winph4
AP Business SummaryBrief at 4:44 p.m. ESTTEMPE, Ariz. (AP) — Caleb McCullough was there for the dark times at Arizona State, when the losses piled up and the cloud of an NCAA investigation was hovering over the program. The senior linebacker opted to stick around, believing in coach Kenny Dillingham's vision for a better future. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
NoneWhat the Options Market Tells Us About RobloxHonoring Excellence: The 2024 National Book Awards
NEW YORK (AP) — U.S. stocks closed at more records after Donald Trump’s latest talk about tariffs created only some ripples on Wall Street. The S&P 500 rose 0.6% to reach another all-time high. The Dow Jones Industrial Average added 0.3% to its own record set the day before, while the Nasdaq composite rose 0.6% as Big Tech stocks helped lead the way. Stock markets abroad saw mostly modest losses, after President-elect Trump said he plans to impose sweeping tariffs on Mexico, Canada and China as soon as he takes office. U.S. automakers and other companies that could be hurt particularly by such tariffs fell. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below.Winless at home, Cowboys shoot for eighth consecutive victory over Giants
OCALA, Fla.--(BUSINESS WIRE)--Nov 27, 2024-- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today issued the following statement refuting the false and misleading claims recently made by a group of activist investors (collectively, the “Activist Group”) relating to their multi-year attempt to take over AIM’s Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”), presently scheduled for December 17, 2024. Since 2016, the Board and management team have worked to overcome multiple obstacles, refocus the Company’s clinical development programs to high-value indications, improve its financial condition and lay the foundation for long-term shareholder value creation. To be clear, the Board and management are unhappy with the Company’s stock price performance – but they are doing everything possible to continue the significant momentum with Ampligen – which is ultimately what will create long-term value for all shareholders. Unfortunately, the Activist Group has accused AIM of lying about its historical share price. The Activist Group, however, is the one who is lying by claiming in its proxy statement: “On February 25, 2016, the day that Mr. Equels assumed the role of CEO, AIM’s stock closed at $87.15.” 1 The truth is that AIM’s stock has never traded anywhere near such a price: The reality is that the Activist Group has lied repeatedly to shareholders. Consider the following instances where its members have been found by the Delaware Court of Chancery (the “Court”) to have lied to or misled shareholders: 1. In 2023, the Activist Group’s 2023 nomination notice obscured the roles of Todd Deutsch, Franz Tudor and others in connection with the 2022 nomination effort and omitted important information regarding the Activist Group’s 2023 nomination effort. 2. The Activist Group also concealed key information related to their nominees’ governance track records on public boards in the 2023 nomination notice. 3. The Activist Group hid its true backers, Mr. Tudor and Michael Xirinachs, in the 2022 nomination notice. 4. The 2022 notice also disguised the true motivations of the Activist Group. Furthermore, the Court confirmed “ The plaintiff’s group – not the Board – are ‘ the ones engaging in manipulative conduct ” 10 by pursuing litigation against AIM. The Delaware Court of Chancery agreed with the Board in both 2022 and 2023. Following the Activist Group’s appeal, the Supreme Court of Delaware upheld the Court’s decision in favor of AIM earlier this year – yet the Activist Group continues to seek reimbursement from AIM for money its members spent on litigation against the Company that they lost . We believe it is highly problematic for a company with a market capitalization of approximately $13 million to reimburse the Activist Group for upwards of $8 million in litigation expenses, especially because the Delaware Supreme Court itself found that they aren’t entitled to them : “The case is not remanded for an award of attorneys’ fees and costs. It is closed. ” 11 AIM encourages shareholders to vote “ FOR ” ALL four of the Board’s incumbent candidates – Stewart L. Appelrouth , Nancy K. Bryan , Thomas K. Equels and Dr. William M. Mitchell – in connection with the Annual Meeting, on the WHITE universal proxy card. For more information on how to vote, visit: www.SafeguardAIM.com . *** About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen ® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. For more information, please visit aimimmuno.com and connect with the Company on X , LinkedIn , and Facebook . Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “continue,” “believe,” “potential,” “upcoming” and other variations thereon and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. Many of these forward-looking statements involve a number of risks and uncertainties. Data, pre-clinical success and clinical success seen to date does not guarantee that Ampligen will be approved as a treatment or therapy for any diseases or conditions. The Company urges investors to consider specifically the various risk factors identified in its most recent Annual Report on Form 10-K, and any risk factors or cautionary statements included in any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K, filed with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Among other things, for those statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the PSLRA. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. Important Additional Information The Company, its directors and executive officers, Peter W. Rodino, III and Robert Dickey, IV, are deemed to be “participants” (as defined in Section 14(a) of the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company’s stockholders in connection with the Annual Meeting. The Company filed its definitive proxy statement (the “Definitive Proxy Statement”) and a WHITE universal proxy card with the SEC on November 4, 2024 in connection with such solicitation of proxies from the Company’s stockholders. STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH DEFINITIVE PROXY STATEMENT, ACCOMPANYING WHITE UNIVERSAL PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING. The Definitive Proxy Statement contains information regarding the identity of the participants, and their direct and indirect interests, by security holdings or otherwise, in the Company’s securities and can be found in the section titled “Principal Stockholders” of the Definitive Proxy Statement and available here . Information regarding subsequent changes to their holdings of the Company’s securities can be found in the SEC filings on Forms 3, 4, and 5, which are available on the Company’s website available here or through the SEC’s website at www.sec.gov . Stockholders will be able to obtain the Definitive Proxy Statement, any amendments or supplements thereto and other documents filed by the Company with the SEC at no charge at the SEC’s website at www.sec.gov . Copies will also be available at no charge at the Company’s website at https://aimimmuno.com/sec-filings/ . ______________________________ 1 The Activist Group’s Definitive Proxy Statement . 2 See the March 2016 Form 8-K , filed with the SEC on March 16, 2016 (emphasis added). 3 See id. ; see also the NYSE American Company Guide . 4 See id. (emphasis added). 5 See December 28, 2023, Opinion of the Delaware Court of Chancery: https://courts.delaware.gov/Opinions/Download.aspx?id=357400 (emphasis added). 6 See id. (emphasis added). 7 See id. (emphasis added). 8 See id. (emphasis added). 9 Jorgl v. AIM ImmunoTech Inc. et al. , 2022 WL 16543834, at *32 (Del. Ch. Oct. 28, 2022). (emphasis added). 10 See December 28, 2023, Opinion of the Delaware Court of Chancery: https://courts.delaware.gov/Opinions/Download.aspx?id=357400 (emphasis added). 11 July 29, 2024, Order on Motion for Reargument of the Delaware Supreme Court. View source version on businesswire.com : https://www.businesswire.com/news/home/20241127594943/en/ CONTACT: Investor Contact: JTC Team, LLC Jenene Thomas 908-824-0775 AIM@jtcir.com Media Contact: Longacre Square Partners Joe Germani / Miller Winston AIM@longacresquare.com KEYWORD: FLORIDA DELAWARE UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY INFECTIOUS DISEASES HEALTH PHARMACEUTICAL ONCOLOGY SOURCE: AIM ImmunoTech Inc. Copyright Business Wire 2024. PUB: 11/27/2024 03:30 PM/DISC: 11/27/2024 03:29 PM http://www.businesswire.com/news/home/20241127594943/en
NoneJudge halts cannabis license lottery that is precursor to Minnesota marijuana retail launch
One of the most talked about issues throughout the 2024 election season was immigration and border control. Social media posts online claim thousands of migrant children have gone missing during Joe Biden’s term as president. During the vice presidential debate in October, Vice President-elect JD Vance claimed there are “320,000 children that DHS has effectively lost.” President-elect Donald Trump made similar remarks throughout his campaign, including at an Arizona rally where he claimed “325,000 migrant children are gone, they’re missing.” Multiple VERIFY readers have asked us if that statistic is accurate. THE QUESTION Did 320,000 migrant children go missing under the Biden Administration? THE SOURCES U.S. Department of Homeland Security report published in August 2024 Immigrant Legal Resource Center (ILRC) Michelle Mittelstadt, director of communications at the Migration Policy Institute told VERIFY. Aaron Reichlin-Melnick, policy director of the American Immigration Council A City of Philadelphia Action Guide An Immigration Impact article THE ANSWER The Department of Homeland Security reported in August that it was unable to monitor the locations of approximately 320,000 migrant children who were released from federal custody, but the report did not declare the kids were missing. WHAT WE FOUND The 320,000 number that Vance and others have referenced comes from a Department of Homeland Security report published in August 2024. The count also includes children who were released during Donald Trump’s presidency, in addition to Biden’s administration. That report said federal authorities may not be able to monitor the locations of about 320,000 unaccompanied migrant children who had been released from federal custody between 2018 and 2023, due in part to poor communication between agencies. But the report did not say that all of the children are lost or missing. Experts also attribute the number of unaccounted for children to missing paperwork – not children who are actually endangered or missing. Instead, the report is referring to the government being unable to track the children after being released from custody. The DHS report “explains that 32,000 unaccompanied children were ordered deported for missing a court hearing from 2019 to 2023,” and that Immigration and Customs Enforcement “had not filed charging documents to start the removal process for 291,000 unaccompanied children who entered the country over that time period,” Aaron Reichlin-Melnick, policy director of the American Immigration Council explained to VERIFY. The claims online combine the 32,000 and the 291,000 counts that appear in the report. Although DHS has stated its inability to monitor the approximate 320,000 migrant children in the United States who did not appear for a hearing or receive a notice, it has not declared them to be missing. There are many factors as to why a child may not have appeared for a hearing or received a notice, including a lack of communication between government agencies to secure the correct mailing address or a guardian’s inability to take them to court. “The issue is a paperwork one – both with ICE not having contact with these minors since their release from HHS custody and lack of communication between ICE and the Justice Department or by a federal agency with the child’s sponsor,” Michelle Mittelstadt, director of communications at the Migration Policy Institute told VERIFY. “The lack of a current address on file does not mean that the children have been trafficked, are lost, or that their parents or sponsors are purposely evading immigration proceedings. Quite the contrary, a majority of the children may be residing in loving homes, attending school, and acclimating to their new surroundings after being reunited with family members in the United States,” an Immigration Impact article explains . Many of the unaccounted for children may have been separated from their parents under Trump’s “zero tolerance” immigration policy, which required children to be separated from their parents during Trump’s first administration. “Upon separation from their families, children are officially labeled ‘unaccompanied alien children,’ before being sent into government custody or foster care, a City of Philadelphia Action Guide explains . The Associated Press contributed to this report.